Authorea (Authorea),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 15, 2023
In
2018,
there
were
significant
cancer
statistics
indicating
8.6
million
cases
of
female
cancers
and
a
global
count
4.2
cancer-related
deaths.
Among
these,
breast
emerged
as
the
most
common
malignancy
in
females,
with
approximately
twenty
percent
progressing
to
metastasis.
Unfortunately,
metastatic
poses
formidable
challenge
for
successful
treatment,
necessitating
urgent
identification
new
molecular
markers
diagnosis
prognostic
prediction,
well
development
innovative
therapeutic
approaches.
One
area
focus
research
involves
differentially
expressed
microRNAs
(miRNAs)
their
role
modifying
expression
genes
associated
tumor
growth.
These
miRNAs
have
been
extensively
studied
context
cancer.
this
overview,
we
summarize
recent
data
regarding
specific
miRNA
profiles
observed
involvement
regulating
various
invasive
processes.
processes
encompass
changes
cytoskeletal
structure,
cell-cell
adhesion
junctions,
interactions
between
cells
extracellular
matrix,
microenvironments,
epithelial-to-mesenchymal
transitions,
acquisition
stem
cell-like
properties.
Additionally,
explore
epigenetic
regulation
individual
other
regulatory
genes.
Furthermore,
examine
function
isoforms
transfer
through
exosomes,
elucidating
contribution
invasiveness.
While
ongoing
continues
unravel
full
extent
functioning
cancer,
outcomes
presented
here
contribute
advancement
management
offer
insights
into
potential
strategies.
Journal of Clinical Laboratory Analysis,
Journal Year:
2021,
Volume and Issue:
35(11)
Published: Sept. 15, 2021
Abstract
Background
Breast
cancer
(BC)
is
by
far
the
most
common
malignancy
among
women.
Epigenetic
modulators,
microRNAs
in
particular,
may
set
stages
for
BC
development
and
its
progression.
Herein,
we
aimed
to
assess
diagnostic
potentiality
of
a
signature
six
miRNAs
(i.e.,
hsa‐miR‐25‐3p,
‐29a‐5p,
‐105‐3p,
‐181b1‐5p,
‐335‐5p,
‐339‐5p)
adjacent
non‐tumor
tissues.
Methods
A
pair
50
tumor
samples
were
taken
from
patients.
The
expression
each
candidate
miRNA
was
measured
using
quantitative
reverse
transcription
PCR.
To
investigate
possible
roles
their
impressions
on
prognosis,
silico
tools
used.
Receiver
operating
characteristic
(ROC)
curves
performed
determine
accuracy
association
with
clinicopathological
characteristics
analyzed.
Results
Our
findings
showed
upregulation
downregulation
hsa‐miR‐335‐5p
‐339‐5p
compared
corresponding
Except
hsa‐miR‐339‐5p,
up‐/down‐regulation
associated
TNM
stages.
hsa‐miR‐105‐3p,
correlated
HER‐2
status.
ROC
curve
analysis
that
six‐miRNA
potential
biomarker
distinguishing
between
breast
tissue
samples.
Conclusion
We
dysregulation
novel
can
be
used
as
diagnosis.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 7762 - 7762
Published: April 24, 2023
MicroRNA
(miRNA)
are
constituted
of
approximately
22
nucleotides
and
play
an
important
role
in
the
regulation
many
physiological
functions
diseases.
In
last
10
years,
increasing
interest
has
been
recorded
studying
expression
profile
miRNAs
cancer.
Real
time-quantitative
polymerase
chain
reaction
(RT-qPCR),
microarrays,
small
RNA
sequencing
represent
gold
standard
techniques
used
30
years
as
detection
methods.
The
advent
nanotechnology
allowed
fabrication
nanostructured
biosensors
which
widely
exploited
diagnostic
field.
Nanostructured
offer
advantages:
(i)
their
size
allows
construction
portable,
wearable,
low-cost
products;
(ii)
large
surface–volume
ratio
enables
loading
a
great
number
biorecognition
elements
(e.g.,
probes,
receptors);
(iii)
direct
contact
recognition
element
with
analyte
increases
sensitivity
specificity
inducing
low
limits
(LOD).
this
review,
miRNA
is
explored,
focusing
on
electrochemical
optical
sensing.
particular,
four
types
nanomaterials
(metallic
nanoparticles,
graphene
oxide,
quantum
dots,
polymers)
reported
for
both
strategies
aim
to
show
distinct
properties
applications.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(5), P. 501 - 501
Published: April 22, 2025
Reactive
oxygen
species
(ROS)
play
a
dual
role
in
cancer
progression,
acting
as
both
signaling
molecules
and
drivers
of
oxidative
damage.
Emerging
evidence
highlights
the
intricate
interplay
between
ROS,
microRNAs
(miRNAs),
exosomes
within
tumor
microenvironment
(TME),
forming
regulatory
axis
that
modulates
immune
responses,
angiogenesis,
therapeutic
resistance.
In
particular,
stress
not
only
stimulates
exosome
biogenesis
but
also
influences
selective
packaging
redox-sensitive
miRNAs
(miR-21,
miR-155,
miR-210)
via
RNA-binding
proteins
such
hnRNPA2B1
SYNCRIP.
These
miRNAs,
delivered
through
exosomes,
alter
gene
expression
recipient
cells
promote
tumor-supportive
phenotypes
M2
macrophage
polarization,
CD8+
T-cell
suppression,
endothelial
remodeling.
This
review
systematically
explores
how
this
ROS–miRNA–exosome
orchestrates
communication
across
stromal
cell
populations
under
hypoxic
inflammatory
conditions.
Particular
emphasis
is
placed
on
NADPH
oxidases,
hypoxia-inducible
factors,
autophagy-related
mechanisms
regulating
exosomal
output.
addition,
we
analyze
relevance
natural
products
herbal
compounds—such
curcumin,
resveratrol,
ginsenosides—which
have
demonstrated
promising
capabilities
to
modulate
ROS
levels,
miRNA
expression,
dynamics.
We
further
discuss
clinical
potential
leveraging
for
therapy,
including
strategies
involving
mesenchymal
stem
cell-derived
ferroptosis
regulation,
miRNA-based
modulation.
Incorporating
insights
from
spatial
transcriptomics
single-cell
analysis,
provides
mechanistic
foundation
development
exosome-centered,
redox-modulating
therapeutics.
Ultimately,
work
aims
guide
future
research
drug
discovery
efforts
toward
integrating
medicine
redox
biology
fight
against
cancer.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 21, 2022
Purpose
To
identify
biomarkers
associated
with
CD8+
T
cells
in
coronary
artery
disease
(CAD)
and
initially
explore
their
potential
role
the
tumor
immune
microenvironment.
Materials
Methods
CAD-related
datasets
GSE12288,
GSE34198,
GSE66360,
were
downloaded
from
GEO
database.
First,
GSVA
was
performed
based
on
GSE12288
dataset.
Then
WGCNA
analysis
to
most
relevant
module
candidate
hub
gene
for
cells,
followed
by
GO
KEGG
of
this
module.
Secondly,
relationship
between
genes
verified
using
GSE34198
which
led
identification
genes.
The
cancer
analyzed
TIMER
Methylation
DiseaseMeth
CAD,
pan-cancer,
pan-cell
lines,
pan-normal
tissues,
correlations
In
addition,
drugs
TFs
predicted,
ceRNA
network
constructed.
Finally,
GSEA
separately
Results
CAD
shown
be
response
analysis.
identified
blue
as
related
nine
relevance
immunity
further
confirmed
Two
additional
validated
three
(FBXO7,
RAD23A,
MKRN1)
that
significantly
correlated
cells.
we
found
positively
TGCT,
THCA,
KICH
cancers
our
Moreover,
differentially
methylated.
We
also
correlation
different
cancers,
cell
normal
tissues.
results
all
analyses
showed
a
positive
them.
successfully
constructed
gene-associated
TF-gene
networks
predicted
11
suggests
are
multiple
processes.
Conclusion
FBXO7,
MKRN1
may
act
through
responses
cancer.
Clinical Medicine Insights Oncology,
Journal Year:
2022,
Volume and Issue:
16
Published: Jan. 1, 2022
Background:
Breast
cancer
(BC)
is
the
most
common
neoplasm
in
women
worldwide.
Liquid
biopsy
(LB)
a
non-invasive
diagnostic
technique
that
allows
analysis
of
biomarkers
different
body
fluids,
particularly
peripheral
blood
and
also
urine,
saliva,
nipple
discharge,
volatile
respiratory
nasal
secretions,
breast
milk,
tears.
The
objective
was
to
analyze
available
evidence
related
use
obtained
by
LB
for
early
diagnosis
BC.
Methods:
Articles
BC
due
LB,
published
between
2010
2022,
from
databases
(WoS,
EMBASE,
PubMed,
SCOPUS)
were
included.
MInCir
scale
applied
articles
determine
their
methodological
quality
(MQ).
Descriptive
statistics
used,
as
well
determination
weighted
averages
each
variable,
extracted
data.
Sensitivity,
specificity,
area
under
curve
values
specific
(individual
or
panels)
are
described.
Results:
In
this
systematic
review
(SR),
136
met
selection
criteria,
representing
17
709
patients
with
However,
95.6%
case-control
studies.
96.3%
cases,
performed
samples.
Most
based
on
microRNA
(miRNA)
analysis.
mean
MQ
score
25/45
points.
have
been
found.
Conclusions:
through
useful
mechanism
miRNA
studied
methodology.
Our
results
indicate
has
high
sensitivity
specificity
BC,
especially
stages.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(11), P. 1352 - 1352
Published: Oct. 24, 2024
Breast
cancer
ranks
first
in
incidence
and
second
deaths
worldwide,
presenting
alarmingly
rising
mortality
rates.
Imaging
methodologies
and/or
invasive
biopsies
are
routinely
used
for
screening
detection,
although
not
always
with
high
sensitivity/specificity.
MicroRNAs
(miRNAs)
could
serve
as
diagnostic
prognostic
biomarkers
breast
cancer.
We
have
designed
a
computational
approach
combining
transcriptome
profiling,
survival
analyses,
power
calculations
from
1165
patients
carcinoma
The
Cancer
Genome
Atlas
(TCGA-BRCA).
Our
strategy
yielded
two
separate
miRNA
signatures
consisting
of
four
up-regulated
five
down-regulated
miRNAs
tumors,
cumulative
strength
AUC
0.93
0.92,
respectively.
provide
direct
evidence
regarding
the
cancer-specific
expression
both
through
multicancer
comparison
>7000
representing
19
solid
types,
challenging
their
potency
beyond
any
current
methods.
functionally
implicated
cancer-related
processes
statistically
significant
effects
on
overall
lymph-node
invasion
patients,
which
underlie
strong
implication.
Collectively,
we
propose
novel
significantly
elevated
resolved
tool
binary
accurate
detection
other
tumors
female
reproductive
system.